BioNTech SE (BNTX) Revenue (2018 - 2025)

BioNTech SE has disclosed Revenue across 8 years of filings, most recently posting $1.1 billion for Q4 2025.

• Revenue for Q4 2025 came in at $1.1 billion, down 99.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 billion (down 99.92% YoY), and the FY2025 annual result was $84.8 million, down 97.11% from the prior year.
• Revenue came in at $1.1 billion for Q4 2025 at BioNTech SE, down from $1.8 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $3526.4 billion in Q4 2024 to a low of $8.8 million in Q2 2025.
• The 5-year median for Revenue is $1.7 billion (2023), against an average of $178.8 billion.
• Across the five-year window, Revenue tumbled 100.0% in 2021 and jumped 221500.66% in 2024, its largest moves.
• BioNTech SE's Revenue stood at $6.3 billion in 2021, then tumbled by 31.03% to $4.4 billion in 2022, then slumped by 63.54% to $1.6 billion in 2023, then surged by 221500.66% to $3526.4 billion in 2024, then slumped by 99.97% to $1.1 billion in 2025.
• The last three Revenue figures came in at $1.1 billion (Q4 2025), $1.8 billion (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.